Candidemia in critically ill patients: difference of outcome between medical and surgical patients
- 187 Downloads
Candidemia is increasingly encountered in critically ill patients with a high fatality rate. The available data in the critically ill suggest that patients with prior surgery are at a higher risk than others. However, little is known about candidemia in medical settings. The main goal of this study was to compare features of candidemia in critically ill medical and surgical patients.
Ten-year retrospective cohort study (1990–2000).
Medical and surgical intensive care units (ICUs) of a teaching hospital.
Fifty-one patients with at least one positive blood culture for Candida species.
Risk factors were retrieved in all of the patients: central venous catheter (92.1%), mechanical ventilation (72.5%), prior bacterial infection (70.6%), high fungal colonization index (45.6%). Candida albicans accounts for 55% of all candidemia. The overall mortality was 60.8% (85% and 45.2% in medical and surgical patients, respectively). Independent factors associated with survival were prior surgery (hazard ratio [HR] =0.25; 0.09–0.67 95% confidence interval [CI], p<0.05), antifungal treatment (HR =0.11; 0.04–0.30 95% CI, p<0.05) and absence of neutropenia (HR =0.10; 0.02–0.45 95% CI, p<0.05). Steroids, neutropenia and high density of fungal colonization were more frequently found among medical patients compared to surgical ones.
Candidemia occurrence is associated with a high mortality rate among critically ill patients. Differences in underlying conditions could account for the poorer outcome of the medical patients. Screening for fungal colonization could allow identification of such high-risk patients and, in turn, improve outcome.
KeywordsCandida Candidemia Prophylaxis Colonization Surgery Outcomes Fungemia
- 2.Jarvis W, Martone W (1992) Predominant pathogens in hospital infections. J Antimicrob Chemther 29:19–24Google Scholar
- 3.Rangel-Frausto M, Wiblin T, Blumberg H, Saiman L, Patterson J, Rinaldi M, Pfaller M, Edwards JJ, Jarvis W, Dawson J, Wenzel R (1999) National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29:253–258PubMedGoogle Scholar
- 4.Vincent J, Bihari D, Suter P, Bruining H, White J, Nicolas-Chanoin M, Wolff M, Spencer R, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–644PubMedGoogle Scholar
- 5.Blumberg H, Jarvis W, Soucie J, Edwards J, Patterson J, Pfaller M, Rangel-Frausto M, Rinaldi M, Saiman L, Wiblin R, Wenzel R (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186PubMedGoogle Scholar
- 7.Nolla-Salas J, Sitges-Serra A, Leon-Gil C, Martinez-Gonzalez J, Leon-Regidor M, Ibanez-Lucia P, Torres-Rodriguez J (1997) Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 23:23–30PubMedGoogle Scholar
- 8.Petri M, Konig J, Moecke H, Gramm H, Barkow H, Kujath P, Dennhart R, Schafer H, Meyer N, Kalmar P, Thulig P, Muller J, Lode H (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 23:317–325PubMedGoogle Scholar
- 15.Komshian S, Uwaydah A, Sobel J, Crane L (1989) Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics and evaluation of factors influencing outcome. Rev Infect Dis 11:379–390Google Scholar
- 17.Pelz R, Hendrix C, Swoboda S, Diener-West M, Merz W, Hammonds J, Lipsett P (1999) A double blind placebo controlled trial of prophylactic fluconazole to prevent candida infections in critically ill surgical patients. Crit Care Med 27: A33Google Scholar
- 18.Ables A, Blumer N, Valainis G, Godeaick M, Palesh Y (1998) Fluconazole prophylaxis of severe infection in trauma and post-surgical patients. Crit Care Med 26:52AGoogle Scholar
- 20.Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D (2002) Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 28:1708–1717CrossRefPubMedGoogle Scholar
- 22.Bone R (1993) The pathogenesis of sepsis. Ann Intern Med 115:457–469Google Scholar
- 23.Vincent J, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J, Hiramatsu Y, Nitenberg G, Nystrom P, Pittet D, Rogers T, Sandven P, Sganga G, Schaller M, Solomkin J (1998) Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24:206–216PubMedGoogle Scholar
- 29.Winston D, Chandrasekar P, Lazarus H, Goodman J, Silber J, Horowitz H, Shadduck R, Rosenfeld C, Ho W, Islam M (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med 118:495–503PubMedGoogle Scholar